LAUREN ULRICH: Open Payments
NPI 1790327187 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,892 in 95 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $786 · 2025 $1,892
Food & beverage: $1,892
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $350 |
| ABBVIE INC. | 17 | $296 |
| PFIZER INC. | 17 | $288 |
| Novo Nordisk Inc | 15 | $269 |
| Amgen Inc. | 7 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $92 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Exact Sciences Corporation | 2 | $33 |
Products named: VRAYLAR, NURTEC ODT, ZEPBOUND, Ozempic, REPATHA, MOUNJARO, CAPLYTA, Wegovy.
Industry payments across MI — which companies pay providers there.
